Atlantic American Corp
NASDAQ:AAME
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Atlantic American Corp
NASDAQ:AAME
|
US |
|
Epiroc AB
STO:EPI A
|
SE |
|
N
|
Nordic Flanges Group AB (publ)
STO:NFGAB
|
SE |
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
DE |
|
A
|
Acom Co Ltd
TSE:8572
|
JP |
|
S
|
Sun Capital Management Corp
TSE:2134
|
JP |
|
Doshisha Co Ltd
TSE:7483
|
JP |
Balance Sheet
Balance Sheet Decomposition
Atlantic American Corp
Atlantic American Corp
Balance Sheet
Atlantic American Corp
| Dec-2001 | Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
69
|
42
|
34
|
41
|
42
|
18
|
37
|
37
|
20
|
28
|
21
|
19
|
33
|
16
|
16
|
13
|
25
|
13
|
13
|
19
|
25
|
29
|
28
|
36
|
|
| Cash Equivalents |
69
|
42
|
34
|
41
|
42
|
18
|
37
|
37
|
20
|
28
|
21
|
19
|
33
|
16
|
16
|
13
|
25
|
13
|
13
|
19
|
25
|
29
|
28
|
36
|
|
| Insurance Receivable |
39
|
40
|
41
|
47
|
38
|
14
|
7
|
8
|
6
|
7
|
8
|
6
|
9
|
11
|
12
|
13
|
13
|
15
|
13
|
28
|
15
|
15
|
24
|
27
|
|
| Deferred Policy Acquisition Cost |
25
|
26
|
28
|
30
|
28
|
20
|
19
|
19
|
20
|
21
|
24
|
26
|
28
|
27
|
28
|
29
|
33
|
37
|
39
|
40
|
39
|
42
|
44
|
45
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
5
|
4
|
3
|
3
|
5
|
|
| Intangible Assets |
0
|
3
|
3
|
3
|
3
|
3
|
2
|
2
|
2
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
|
| Goodwill |
19
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
199
|
250
|
285
|
279
|
277
|
193
|
178
|
173
|
195
|
200
|
230
|
247
|
229
|
240
|
238
|
244
|
248
|
242
|
269
|
279
|
283
|
229
|
237
|
230
|
|
| Other Long-Term Assets |
2
|
1
|
0
|
1
|
7
|
196
|
200
|
11
|
6
|
3
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
4
|
0
|
0
|
2
|
14
|
16
|
18
|
|
| Other Assets |
78
|
60
|
52
|
70
|
66
|
15
|
15
|
17
|
13
|
16
|
16
|
20
|
18
|
20
|
17
|
17
|
23
|
31
|
36
|
32
|
32
|
32
|
28
|
30
|
|
| Total Assets |
412
N/A
|
422
+2%
|
444
+5%
|
471
+6%
|
460
-2%
|
459
0%
|
458
0%
|
267
-42%
|
262
-2%
|
278
+6%
|
302
+9%
|
320
+6%
|
319
0%
|
317
-1%
|
315
-1%
|
319
+1%
|
343
+8%
|
344
+0%
|
378
+10%
|
405
+7%
|
402
-1%
|
367
-9%
|
381
+4%
|
393
+3%
|
|
| Liabilities | |||||||||||||||||||||||||
| Insurance Policy Liabilities |
243
|
254
|
264
|
292
|
286
|
134
|
128
|
131
|
129
|
138
|
147
|
155
|
162
|
164
|
163
|
163
|
174
|
189
|
202
|
199
|
202
|
203
|
212
|
225
|
|
| Accounts Payable |
0
|
0
|
0
|
0
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
5
|
4
|
4
|
3
|
5
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
37
|
39
|
36
|
36
|
35
|
33
|
36
|
19
|
14
|
16
|
14
|
12
|
15
|
14
|
15
|
17
|
22
|
20
|
18
|
21
|
21
|
23
|
22
|
26
|
|
| Total Current Liabilities |
37
|
39
|
36
|
36
|
42
|
33
|
36
|
19
|
14
|
16
|
14
|
12
|
15
|
14
|
15
|
17
|
22
|
20
|
24
|
26
|
26
|
27
|
25
|
31
|
|
| Long-Term Debt |
44
|
50
|
56
|
53
|
52
|
54
|
54
|
41
|
41
|
41
|
41
|
41
|
41
|
34
|
34
|
34
|
34
|
34
|
34
|
34
|
34
|
36
|
37
|
38
|
|
| Deferred Income Tax |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
7
|
0
|
1
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
144
|
152
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
325
N/A
|
343
+6%
|
357
+4%
|
382
+7%
|
380
0%
|
365
-4%
|
371
+2%
|
191
-48%
|
185
-3%
|
195
+6%
|
206
+6%
|
214
+4%
|
219
+2%
|
213
-3%
|
212
0%
|
213
+0%
|
230
+8%
|
243
+5%
|
259
+7%
|
260
+0%
|
261
+0%
|
265
+1%
|
274
+3%
|
294
+7%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
22
|
22
|
22
|
22
|
22
|
22
|
22
|
23
|
23
|
23
|
23
|
23
|
23
|
23
|
23
|
23
|
23
|
23
|
23
|
23
|
23
|
23
|
23
|
22
|
|
| Retained Earnings |
1
|
11
|
5
|
1
|
3
|
5
|
11
|
5
|
3
|
4
|
6
|
9
|
19
|
22
|
25
|
27
|
31
|
37
|
36
|
48
|
51
|
52
|
51
|
46
|
|
| Additional Paid In Capital |
57
|
55
|
52
|
50
|
49
|
56
|
56
|
57
|
57
|
57
|
57
|
57
|
57
|
57
|
57
|
57
|
58
|
57
|
58
|
57
|
57
|
57
|
57
|
57
|
|
| Unrealized Security Profit/Loss |
9
|
13
|
18
|
17
|
13
|
12
|
1
|
9
|
5
|
0
|
0
|
0
|
6
|
9
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
1
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
3
|
5
|
6
|
7
|
7
|
8
|
8
|
7
|
8
|
7
|
7
|
7
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
12
|
20
|
1
|
1
|
4
|
5
|
9
|
8
|
10
|
25
|
18
|
22
|
16
|
19
|
|
| Total Equity |
88
N/A
|
79
-10%
|
87
+11%
|
89
+2%
|
81
-10%
|
94
+17%
|
88
-7%
|
75
-14%
|
78
+3%
|
83
+7%
|
96
+16%
|
106
+10%
|
101
-5%
|
104
+3%
|
103
-2%
|
106
+3%
|
113
+7%
|
101
-10%
|
118
+17%
|
145
+23%
|
141
-3%
|
102
-28%
|
107
+5%
|
100
-7%
|
|
| Total Liabilities & Equity |
412
N/A
|
422
+2%
|
444
+5%
|
471
+6%
|
460
-2%
|
459
0%
|
458
0%
|
267
-42%
|
262
-2%
|
278
+6%
|
302
+9%
|
320
+6%
|
319
0%
|
317
-1%
|
315
-1%
|
319
+1%
|
343
+8%
|
344
+0%
|
378
+10%
|
405
+7%
|
402
-1%
|
367
-9%
|
381
+4%
|
393
+3%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
21
|
21
|
21
|
21
|
21
|
22
|
22
|
22
|
22
|
22
|
21
|
21
|
21
|
21
|
20
|
20
|
20
|
20
|
21
|
20
|
20
|
20
|
20
|
20
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|